AtaiBeckley (ATAI) Interest Coverage Ratio (2022 - 2025)
AtaiBeckley (ATAI) posted quarterly Interest Coverage Ratio of 0.52 for Q1 2026, up 97.69% year-over-year from 0.26 in Q1 2025, and up 97.69% quarter-over-quarter from 22.63 in Q1 2025.
Analysis
AtaiBeckley (ATAI) Interest Coverage Ratio (2022 - 2025) Analysis & Trends
AtaiBeckley has reported Interest Coverage Ratio for 6 years, with the latest figure at 0.24 in Q3 2025.
- Quarterly Interest Coverage Ratio rose 96.43% year-over-year to 0.24 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.88 (up 97.21% YoY) and the FY2024 annual result came in at 0.74, up 47.22% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 0.52, up from 22.63 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 0.52 in Q1 2026, with the low at 22.63 in Q1 2025.
- A 5-year average of 3.95 and a median of 3.12 in 2023 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2021 and 2023: Interest Coverage Ratio sank 12532.24% in 2021, then jumped 2063.38% in 2023.
- Over 5 years, Interest Coverage Ratio stood at 0.15 in 2021, then sank by 26217.41% to 40.7 in 2022, then jumped by 2063.38% to 799.07 in 2023, then tumbled by 97.73% to 18.1 in 2024, then tumbled by 101.32% to 0.24 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.24, 1.3, and 22.63 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -95.73 |
| Jun 30, 2025 | -95.73 |
| Mar 31, 2025 | -22.63 |
| Mar 31, 2025 | -22.63 |
| Dec 31, 2024 | -31.79 |
| Sep 30, 2024 | -28.87 |
| Jun 30, 2024 | -36.65 |
| Mar 31, 2024 | -35.06 |
| Dec 31, 2023 | -48.57 |
| Sep 30, 2023 | -39.12 |
| Jun 30, 2023 | -48.42 |
| Mar 31, 2023 | -53.40 |
| Dec 31, 2022 | -40.70 |